Hui Chen, Yihong Ding, Liyan Huang, Wansi Zhong, Xiaojun Lin, Baoyue Zhang, Yan Zheng, Xin Xu, Min Lou, Changzheng Yuan
{"title":"与过敏相关和非过敏相关的老年人嗅觉障碍与认知功能的关系:两项横断面研究","authors":"Hui Chen, Yihong Ding, Liyan Huang, Wansi Zhong, Xiaojun Lin, Baoyue Zhang, Yan Zheng, Xin Xu, Min Lou, Changzheng Yuan","doi":"10.2174/0115672050284179240215052257","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Evidence on the association of Olfactory Impairment (OI) with age-related cognitive decline is inconclusive, and the potential influence of allergy remains unclear.</p><p><strong>Objective: </strong>We aimed to evaluate the cross-sectional associations of allergy-related and non-allergy- related OI to cognitive function.</p><p><strong>Methods: </strong>We included 2,499 participants from the Health and Retirement Study (HRS)-Harmonized Cognitive Assessment Protocol (HCAP) sub-study and 1,086 participants from the English Longitudinal Study of Ageing (ELSA)-HCAP. The Olfactory Function Field Exam (OFFE) using Sniffin' Stick odor pens was used to objectively assess olfactory function and an olfactory score <6/11 indicated OI. Mini-Mental Status Examination (MMSE) was used to assess global cognitive function and define cognitive impairment (<24/30). A neuropsychologic battery was used to assess five cognitive domains.</p><p><strong>Results: </strong>Compared to non-OI participants, individuals with OI had lower MMSE z-score [β<sub>HRS</sub> = -0.33, 95% Confidence Interval (CI): -0.41 to -0.24; β<sub>ELSA</sub> = -0.31, -0.43 to -0.18] and higher prevalence of cognitive impairment (Prevalence Ratio (PR)HRS = 1.46, 1.06 to 2.01; PR<sub>ELSA</sub> = 1.63, 1.26 to 2.11). The associations were stronger for non-allergy-related OI (β<sub>HRS</sub> = -0.36; β<sub>ELSA</sub> = -0.34) than for allergy-related OI (β<sub>HRS</sub> = -0.26; β<sub>ELSA</sub> = 0.13). Similar associations were observed with domain- specific cognitive function measures.</p><p><strong>Conclusion: </strong>OI, particularly non-allergy-related OI, was related to poorer cognitive function in older adults. Although the current cross-sectional study is subject to several limitations, such as reverse causality and residual confounding, the findings will provide insights into the OI-cognition association and enlighten future attention to non-allergy-related OI for the prevention of potential cognitive impairment.</p>","PeriodicalId":94309,"journal":{"name":"Current Alzheimer research","volume":" ","pages":"811-820"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Association of Allergy-Related and Non-Allergy-Related Olfactory Impairment with Cognitive Function in Older Adults: Two Cross- Sectional Studies.\",\"authors\":\"Hui Chen, Yihong Ding, Liyan Huang, Wansi Zhong, Xiaojun Lin, Baoyue Zhang, Yan Zheng, Xin Xu, Min Lou, Changzheng Yuan\",\"doi\":\"10.2174/0115672050284179240215052257\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Evidence on the association of Olfactory Impairment (OI) with age-related cognitive decline is inconclusive, and the potential influence of allergy remains unclear.</p><p><strong>Objective: </strong>We aimed to evaluate the cross-sectional associations of allergy-related and non-allergy- related OI to cognitive function.</p><p><strong>Methods: </strong>We included 2,499 participants from the Health and Retirement Study (HRS)-Harmonized Cognitive Assessment Protocol (HCAP) sub-study and 1,086 participants from the English Longitudinal Study of Ageing (ELSA)-HCAP. The Olfactory Function Field Exam (OFFE) using Sniffin' Stick odor pens was used to objectively assess olfactory function and an olfactory score <6/11 indicated OI. Mini-Mental Status Examination (MMSE) was used to assess global cognitive function and define cognitive impairment (<24/30). A neuropsychologic battery was used to assess five cognitive domains.</p><p><strong>Results: </strong>Compared to non-OI participants, individuals with OI had lower MMSE z-score [β<sub>HRS</sub> = -0.33, 95% Confidence Interval (CI): -0.41 to -0.24; β<sub>ELSA</sub> = -0.31, -0.43 to -0.18] and higher prevalence of cognitive impairment (Prevalence Ratio (PR)HRS = 1.46, 1.06 to 2.01; PR<sub>ELSA</sub> = 1.63, 1.26 to 2.11). The associations were stronger for non-allergy-related OI (β<sub>HRS</sub> = -0.36; β<sub>ELSA</sub> = -0.34) than for allergy-related OI (β<sub>HRS</sub> = -0.26; β<sub>ELSA</sub> = 0.13). Similar associations were observed with domain- specific cognitive function measures.</p><p><strong>Conclusion: </strong>OI, particularly non-allergy-related OI, was related to poorer cognitive function in older adults. Although the current cross-sectional study is subject to several limitations, such as reverse causality and residual confounding, the findings will provide insights into the OI-cognition association and enlighten future attention to non-allergy-related OI for the prevention of potential cognitive impairment.</p>\",\"PeriodicalId\":94309,\"journal\":{\"name\":\"Current Alzheimer research\",\"volume\":\" \",\"pages\":\"811-820\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Alzheimer research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0115672050284179240215052257\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Alzheimer research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115672050284179240215052257","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Association of Allergy-Related and Non-Allergy-Related Olfactory Impairment with Cognitive Function in Older Adults: Two Cross- Sectional Studies.
Background: Evidence on the association of Olfactory Impairment (OI) with age-related cognitive decline is inconclusive, and the potential influence of allergy remains unclear.
Objective: We aimed to evaluate the cross-sectional associations of allergy-related and non-allergy- related OI to cognitive function.
Methods: We included 2,499 participants from the Health and Retirement Study (HRS)-Harmonized Cognitive Assessment Protocol (HCAP) sub-study and 1,086 participants from the English Longitudinal Study of Ageing (ELSA)-HCAP. The Olfactory Function Field Exam (OFFE) using Sniffin' Stick odor pens was used to objectively assess olfactory function and an olfactory score <6/11 indicated OI. Mini-Mental Status Examination (MMSE) was used to assess global cognitive function and define cognitive impairment (<24/30). A neuropsychologic battery was used to assess five cognitive domains.
Results: Compared to non-OI participants, individuals with OI had lower MMSE z-score [βHRS = -0.33, 95% Confidence Interval (CI): -0.41 to -0.24; βELSA = -0.31, -0.43 to -0.18] and higher prevalence of cognitive impairment (Prevalence Ratio (PR)HRS = 1.46, 1.06 to 2.01; PRELSA = 1.63, 1.26 to 2.11). The associations were stronger for non-allergy-related OI (βHRS = -0.36; βELSA = -0.34) than for allergy-related OI (βHRS = -0.26; βELSA = 0.13). Similar associations were observed with domain- specific cognitive function measures.
Conclusion: OI, particularly non-allergy-related OI, was related to poorer cognitive function in older adults. Although the current cross-sectional study is subject to several limitations, such as reverse causality and residual confounding, the findings will provide insights into the OI-cognition association and enlighten future attention to non-allergy-related OI for the prevention of potential cognitive impairment.